Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Choi, Y. | - |
dc.contributor.author | Park, B. | - |
dc.contributor.author | Kim, K. | - |
dc.contributor.author | Jeong, B. C. | - |
dc.contributor.author | Seo, S. I. | - |
dc.contributor.author | Jeon, S. S. | - |
dc.contributor.author | Choi, H. Y. | - |
dc.contributor.author | Lee, J. E. | - |
dc.contributor.author | Lee, H. M. | - |
dc.date.available | 2021-02-22T12:16:48Z | - |
dc.date.issued | 2013-02-05 | - |
dc.identifier.issn | 0007-0920 | - |
dc.identifier.issn | 1532-1827 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/11342 | - |
dc.description.abstract | Background: The 1997 international consensus conference on renal cell cancer (RCC) prognosis suggested erythrocyte sedimentation rate (ESR), alkaline phosphatase (ALP), and anaemia as prognostic biomarkers, but most studies reviewed were limited by small sample sizes. Methods: The Cox proportional hazards model was used to evaluate whether ESR, ALP, haemoglobin (Hb), and haematocrit (Hct) could predict survival outcomes in 1307 patients with clear cell RCC (ccRCC) who underwent nephrectomy during 1994-2008. Results: During a median follow-up of 43 months, we found that the patients with preoperative high levels of ESR, had a 2.10-fold (95% confidence interval (CI): 1.21-3.67) greater risk of dying from RCC compared with patients with low levels (normal range). Patients with preoperative anaemia, assessed by Hb and Hct, had a 3.11-fold (95% CI: 1.17-8.25) and 6.20-fold (95% CI: 2.30-16.72) greater risk of dying from other illnesses, respectively, compared with patients without anaemia. ALP levels were not associated with ccRCC patients' survival. These associations for ESR and anaemia were more pronounced in patients with body mass index (BMI) <25 compared with patients with BMI >= 25 kg m(-2). Conclusion: Preoperative high ESR, but not ALP, was a significant predictor for cancer-specific survival among ccRCC patients. Anaemia increases the risk of death from other illness. | - |
dc.format.extent | 8 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | NATURE PUBLISHING GROUP | - |
dc.title | Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1038/bjc.2012.565 | - |
dc.identifier.scopusid | 2-s2.0-84873736157 | - |
dc.identifier.wosid | 000314800900019 | - |
dc.identifier.bibliographicCitation | BRITISH JOURNAL OF CANCER, v.108, no.2, pp 387 - 394 | - |
dc.citation.title | BRITISH JOURNAL OF CANCER | - |
dc.citation.volume | 108 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 387 | - |
dc.citation.endPage | 394 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | sci | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | PROGNOSTIC-SIGNIFICANCE | - |
dc.subject.keywordPlus | INFLAMMATION | - |
dc.subject.keywordAuthor | renal cell carcinoma | - |
dc.subject.keywordAuthor | survival | - |
dc.subject.keywordAuthor | erythrocyte sedimentation rate | - |
dc.subject.keywordAuthor | anaemia | - |
dc.subject.keywordAuthor | prognostic biomarkers | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.